Navigation Links
Eyeing Trouble! Doctor in a blind spot.

While it is the legal norm to take the consent of patients prior to medical trials, a famous eye surgeon has confessed to initiating// medical trials without obtaining approval from the patients.

Dr Deepak Chitkara, 46, from Liverpool, found himself in a blind spot after he inserted "untested" lenses into patients' eyes as part of a study. Following this, Mr. Chitkara, lost his job at the Rosen Eye clinic, but has since started his own practice.

It is understood that the firm Lenstech had appointed Dr Chitkara as a consultant director and were paying him $4,330 (£2,370) a month, mainly for his assistance in promoting their Kellan brand of lens. The doctor is believed to have also received commission on the sale of these lenses. Apparently, the doctor inserted Kellan brand of lens in one eye of the patient and a lens made by a rival brand in another, with a view to test the lens. This procedure was conducted without the consent of the patients.

Dr Chitkara has admitted to use of the lenses in patients without their consent. He said "My use of the lenses was not decided by financial incentive."


'"/>




Page: 1

Related medicine news :

1. Dr Reddys Eyeing for Generics Arm of Merck
2. Cancer Doctors Okays Controversial Prostate Therapy
3. Doctors needed urgently in Gujarat
4. Doctors operate upon patients in candlelight- latest from the quake scene
5. Doctors at risk- the ugly side of the noble profession
6. Doctors advice early anemia tests
7. Indian Doctor granted US patent on organ regeneration
8. Emphasis to ban Drugs ads by Doctors
9. Doctor samples come under the ambit of advertisement
10. Doctors not to accept gifts from drug companies
11. Gene testing kit specific for Doctors
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2016)... ... 03, 2016 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... New York City, with long-time partners The Paul Foundation, on November 10, 2016. ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... Entrepreneurial Company in the Dallas area” Tuesday evening at the 26th Annual SMU ... presented by SMU's Cox School’s Caruth Institute for Entrepreneurship. Dallas 100™, co-founded by ...
(Date:12/4/2016)... , ... December 04, 2016 , ... Responsible dental care ... must brush properly to achieve optimal results. This important necessity inspired an inventor from ... for a way to ensure that people break or avoid bad techniques of brushing ...
(Date:12/2/2016)... SAN DIEGO, Calif. (PRWEB) , ... December 02, 2016 , ... ... Recognition Event at the Hard Rock Hotel San Diego honoring the 2016 MPN Heroes—eight ... as myeloproliferative neoplasms (MPNs) by going above and beyond the standard of care, demonstrating ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... announces the launch of its 60-day free trial program for all of the ... make the offer a truly hassle free experience. , FlexiSpot’s unique desktop risers ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... 2016   Pairnomix, LLC, a genetic research company ... by the White House, today announced that findings from its ... of candidate therapies for a patient with epileptic encephalopathy caused ... presented at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process ...
(Date:12/4/2016)... , Dec. 3, 2016  Results from the Phase ... an anti-P-selectin antibody, reduced the median annual rate of ... placebo (1.63 vs 2.98, p=0.010) in patients with or ... the data are being featured in the official press ... Hematology (ASH) Annual Meeting and presented during the Plenary ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology: